373 related articles for article (PubMed ID: 27828912)
21.
Zhu T; Chen DF; Wang L; Wu S; Wei X; Li H; Jin ZB; Sui R
Br J Ophthalmol; 2021 May; 105(5):694-703. PubMed ID: 32675063
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of microvascular abnormalities using OCT angiography in patients with biallelic variants in
Hagag AM; Mitsios A; Gill JS; Nunez Do Rio JM; Theofylaktopoulos V; Houston S; Webster AR; Dubis AM; Moosajee M
Br J Ophthalmol; 2020 Apr; 104(4):480-486. PubMed ID: 31266775
[TBL] [Abstract][Full Text] [Related]
23. Mutations in myosin VIIA (MYO7A) and usherin (USH2A) in Spanish patients with Usher syndrome types I and II, respectively.
Nájera C; Beneyto M; Blanca J; Aller E; Fontcuberta A; Millán JM; Ayuso C
Hum Mutat; 2002 Jul; 20(1):76-7. PubMed ID: 12112664
[TBL] [Abstract][Full Text] [Related]
24. Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene.
Sandberg MA; Rosner B; Weigel-DiFranco C; McGee TL; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5532-9. PubMed ID: 18641288
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes.
Feenstra HM; Al-Khuzaei S; Shah M; Broadgate S; Shanks M; Kamath A; Yu J; Jolly JK; MacLaren RE; Clouston P; Halford S; Downes SM
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011334
[TBL] [Abstract][Full Text] [Related]
26. Fundus autofluorescence and optical coherence tomography in relation to visual function in Usher syndrome type 1 and 2.
Fakin A; Jarc-Vidmar M; Glavač D; Bonnet C; Petit C; Hawlina M
Vision Res; 2012 Dec; 75():60-70. PubMed ID: 23000274
[TBL] [Abstract][Full Text] [Related]
27. Novel USH2A mutations in Israeli patients with retinitis pigmentosa and Usher syndrome type 2.
Kaiserman N; Obolensky A; Banin E; Sharon D
Arch Ophthalmol; 2007 Feb; 125(2):219-24. PubMed ID: 17296898
[TBL] [Abstract][Full Text] [Related]
28. Disease boundaries in the retina of patients with Usher syndrome caused by MYO7A gene mutations.
Jacobson SG; Aleman TS; Sumaroka A; Cideciyan AV; Roman AJ; Windsor EA; Schwartz SB; Rehm HL; Kimberling WJ
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1886-94. PubMed ID: 19074810
[TBL] [Abstract][Full Text] [Related]
29. Usher Syndrome on the Island of Ireland: A Genotype-Phenotype Review.
Stephenson KAJ; Whelan L; Zhu J; Dockery A; Wynne NC; Cairns RM; Kirk C; Turner J; Duignan ES; O'Byrne JJ; Silvestri G; Kenna PF; Farrar GJ; Keegan DJ
Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):23. PubMed ID: 37466950
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of USH2A mutations in Scandinavian patients with Usher syndrome type II.
Dreyer B; Brox V; Tranebjaerg L; Rosenberg T; Sadeghi AM; Möller C; Nilssen O
Hum Mutat; 2008 Mar; 29(3):451. PubMed ID: 18273898
[TBL] [Abstract][Full Text] [Related]
31. New compound heterozygous USH2A mutations in Usher syndrome.
Kuang L; Chen Q; Gan R; Yan X
Acta Ophthalmol; 2020 Feb; 98(1):e134-e135. PubMed ID: 30390381
[No Abstract] [Full Text] [Related]
32. Prevalence and genetic-phenotypic characteristics of patients with
Gao FJ; Wang DD; Chen F; Sun HX; Hu FY; Xu P; Li J; Liu W; Qi YH; Li W; Wang M; Zhang S; Xu GZ; Chang Q; Wu JH
Br J Ophthalmol; 2021 Jan; 105(1):87-92. PubMed ID: 32188678
[TBL] [Abstract][Full Text] [Related]
33. The roles of USH1 proteins and PDZ domain-containing USH proteins in USH2 complex integrity in cochlear hair cells.
Zou J; Chen Q; Almishaal A; Mathur PD; Zheng T; Tian C; Zheng QY; Yang J
Hum Mol Genet; 2017 Feb; 26(3):624-636. PubMed ID: 28031293
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the ternary Usher syndrome SANS/ush2a/whirlin protein complex.
Sorusch N; Bauß K; Plutniok J; Samanta A; Knapp B; Nagel-Wolfrum K; Wolfrum U
Hum Mol Genet; 2017 Mar; 26(6):1157-1172. PubMed ID: 28137943
[TBL] [Abstract][Full Text] [Related]
35. Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.
Duncan JL; Liang W; Maguire MG; Audo I; Ayala AR; Birch DG; Carroll J; Cheetham JK; Esposti SD; Durham TA; Erker L; Farsiu S; Ferris FL; Heon E; Hufnagel RB; Iannaccone A; Jaffe GJ; Kay CN; Michaelides M; Pennesi ME; Sahel JA;
Am J Ophthalmol; 2020 Nov; 219():87-100. PubMed ID: 32446738
[TBL] [Abstract][Full Text] [Related]
36. Targeted next-generation sequencing reveals novel USH2A mutations associated with diverse disease phenotypes: implications for clinical and molecular diagnosis.
Chen X; Sheng X; Liu X; Li H; Liu Y; Rong W; Ha S; Liu W; Kang X; Zhao K; Zhao C
PLoS One; 2014; 9(8):e105439. PubMed ID: 25133613
[TBL] [Abstract][Full Text] [Related]
37. Retinal disease course in Usher syndrome 1B due to MYO7A mutations.
Jacobson SG; Cideciyan AV; Gibbs D; Sumaroka A; Roman AJ; Aleman TS; Schwartz SB; Olivares MB; Russell RC; Steinberg JD; Kenna MA; Kimberling WJ; Rehm HL; Williams DS
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7924-36. PubMed ID: 21873662
[TBL] [Abstract][Full Text] [Related]
38. An Usher syndrome type 1 patient diagnosed before the appearance of visual symptoms by MYO7A mutation analysis.
Yoshimura H; Iwasaki S; Kanda Y; Nakanishi H; Murata T; Iwasa Y; Nishio SY; Takumi Y; Usami S
Int J Pediatr Otorhinolaryngol; 2013 Feb; 77(2):298-302. PubMed ID: 23237960
[TBL] [Abstract][Full Text] [Related]
39. Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism.
Jacobson SG; Cideciyan AV; Aleman TS; Sumaroka A; Roman AJ; Gardner LM; Prosser HM; Mishra M; Bech-Hansen NT; Herrera W; Schwartz SB; Liu XZ; Kimberling WJ; Steel KP; Williams DS
Hum Mol Genet; 2008 Aug; 17(15):2405-15. PubMed ID: 18463160
[TBL] [Abstract][Full Text] [Related]
40. Partial USH2A deletions contribute to Usher syndrome in Denmark.
Dad S; Rendtorff ND; Kann E; Albrechtsen A; Mehrjouy MM; Bak M; Tommerup N; Tranebjærg L; Rosenberg T; Jensen H; Møller LB
Eur J Hum Genet; 2015 Dec; 23(12):1646-51. PubMed ID: 25804404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
